IQVIA (NYSE:IQV) Coverage Initiated by Analysts at Royal Bank of Canada

Royal Bank of Canada started coverage on shares of IQVIA (NYSE:IQV – Free Report) in a research report released on Wednesday, Marketbeat Ratings reports. The firm issued an outperform rating and a $275.00 target price on the medical research company’s stock. Several other research firms have also weighed in on IQV. Evercore ISI boosted their […]

Leave a Reply

Your email address will not be published.

Previous post Compass Point Begins Coverage on Visa (NYSE:V)
Next post Liberty Latin America (NASDAQ:LILAK) Earns “Neutral” Rating from The Goldman Sachs Group